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ABSTRACT 
Objective 
A cross-sectional study assessed cognitive function in a sample of Adult Congenital Heart 
Disease patients, within the Functioning in Adult Congenital Heart Disease study London. The 
association between cognitive functioning and disease complexity was examined.  
Methods  
Three hundred and ten patients participated. Patients were classified into four structural 
complexity groups (Tetralogy of Fallot, Transposition of the Great Arteries, Single Ventricle and 
Simple conditions). Each participant underwent neuropsychological assessment to evaluate 
cognitive function (memory, executive function) and completed questionnaires to assess 
depression and anxiety.  
Results  
Forty one percent of the sample showed impaired performance (>1.5 SD below the normative 
mean) on at least 3 tests of cognitive function compared to established normative data. This was 
higher than the 8% that would be expected in a normal population. The sample exhibited 
significant deficits in divided attention, motor function and executive functioning. There was a 
significant group difference in divided attention (F=5.01, p=.002) and mean total composite score 
(F=5.19, p=.002) between different structural complexity groups with the Simple group 
displaying better cognitive function. 
Conclusion 
The results indicate that many Adult Congenital Heart Disease patients display impaired 
cognitive function relative to a healthy population, which differs in relation to disease 
complexity. These findings may have implications for clinical decision making in this group of 
patients during childhood. Possible mechanisms underlying these deficits and how they may be 
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reduced or prevented are discussed; however further work is needed to draw conclusive 
judgments.  
 
INTRODUCTION 
Recent advances in medical and surgical techniques have significantly changed the outlook for 
patients with congenital heart disease, giving rise to a new group of patients: Adults with 
Congenital Heart Disease. Until recently, approximately 50% of these patients would not have 
survived through childhood but a large proportion can now be expected to survive into adulthood 
(85%).1 In the UK an estimated 1,600 Congenital Heart Disease patients reaching 16 years of age 
are referred for follow-up care in adult services each year.2 A similar rise has also been reported 
in Canada.,3 
 
The steady rise in the number of survivors with Congenital Heart Disease has shifted attention to 
the long-term impact of the condition for this new patient population. Interest is moving away 
from mortality to long-term psychosocial outcomes such as quality of life, social functioning and 
wellbeing.4  
 
One potential difficultly affecting this patient group is impairment of cognitive function. Existing 
literature indicates a relationship between Congenital Heart Disease, its related treatments and 
patients’ cognitive functioning. However this research has largely focused on child cohorts.5 The 
impact of Congenital Heart Disease on cognition in adults is relatively understudied despite 
recent research suggesting cognitive impairment persists into adolescence.6 
 
The primary focus of research on cognitive functioning has been on the assessment of IQ in both 
child and adult patients. A recent meta-analysis suggested that IQ was adversely affected in 
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children with complex heart defects but remained within the normal range in those with simpler 
forms of Congenital Heart Disease.7 The limited adult literature suggests that IQ is relatively 
unaffected in Adult Congenital Heart Disease.5 To date only one study has reported lower IQ in  
Adult Congenital Heart Disease patients in comparison to a normal group.8 While informative, 
the assessment of IQ alone does not provide a comprehensive and clear understanding of 
cognitive function, as it fails to capture performance in specific domains of cognition, such as 
memory, executive functioning, verbal fluency and attention. 
 
Preliminary research in child cohorts has reported cognitive deficits across a range of domains, in 
particular language, psychomotor functioning, visuo-spatial skills, attention and memory.8- 11 In a 
review of the literature we identified only 5 studies that examined cognition in Adult Congenital 
Heart Disease (two on the same cohort),5,8, 12-15  of which only one study tested cognitive domains 
beyond IQ. These patients exhibited significant impairment of executive function and marginal 
memory, attention and learning deficits suggesting that patients may have difficulty with 
planning, dealing with novel situations, learning and recalling new information and remaining 
focused on a task. However, this sample was restricted to Tetralogy of Fallot and hence does not 
provide an understanding of the cognitive problems in different forms of Adult Congenital Heart 
Disease.9  
 
The literature is further limited by the inclusion of heterogeneous patient samples in many 
studies. The varying complexity, treatment regimens and associated complications seen across 
congenital heart conditions is likely to differentially impact upon cognition. Greater cognitive 
impairment may be expected in cyanotic conditions due to increased risk of cerebral hypoxia.16 
Similarly patients with more complex forms of Congenital Heart Disease and those requiring 
multiple surgical interventions may be at increased risk of cognitive impairment. Research has 
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suggested that micro emboli entering cerebral blood flow during cardiopulmonary bypass may 
cause infarcts resulting in cerebral injury and consequent cognitive impairment.17 Grouping 
patients with diverse forms of Adult Congenital Heart Disease may mask the true nature of the 
relationship between Adult Congenital Heart Disease and cognitive impairment.   
 
This study assessed cognitive function in a group of Adult Congenital Heart Disease patients 
from different structural complexity groups with varying levels of morphological complexity, on 
a wide range of domains of cognitive function. The study aimed to (a) assess the level of 
cognitive functioning in Adult Congenital Heart Disease patients in comparison to age-matched 
norms and (b) investigate differences in cognitive function between different Adult Congenital 
Heart Disease structural complexity groups.  
 
METHODS  
Participants 
Participants were recruited from the Grown Up Congenital Heart Unit at the Heart Hospital, 
University College Hospital, London, UK. Inclusion criteria were: (a) age 16 years or over, (b) 
diagnosis of Congenital Heart Disease, (c) fluent in English. Exclusion criteria included (a) 
presence of chromosomal anomalies: Trisomy-21 (Downs Syndrome), 22q11deletion (Di George 
syndrome), (b) history of stroke, (c) presence of mental retardation and learning difficulties, (d) 
Patent Foramen Ovale without any other structural anomaly, (e) physically disabled (unable to 
undergo exercise testing and/or neuropsychological assessment) and (f) presence of sensory loss 
or communication difficulty sufficient to interfere with the assessment.  
 
Patient classification 
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Patients were classified into four groups based on the morphological complexity of the congenital 
heart condition: i) Tetralogy of Fallot diagnosis, pulmonary atresia, major aortopulmonary 
collateral arteries, pulmonary valve replacement), ii) Transposition of the Great Arteries 
diagnosis, atrial switch operation), iii) Single Ventricle (Single Ventricle physiology, Fontan 
repair operation) and iv) Simple (atrial septal defect, ventricular septal defect, coarctation of the 
aorta (including re-coarctation). Groups i-iii represent cyanotic, and group iv acyanotic, 
conditions.  A sample size calculation indicated that for a four-group study to detect significant 
group difference on cognitive functioning, 280 participants were required to attain 80% power to 
detect a small-medium effect size, at the 0.05 significance level.  
 
Procedure  
A purposive sample of patients was recruited into the four structural complexity groups from 
patient databases and outpatient clinic lists. From an estimated 5000 patients 1199 were assessed 
for eligibility, 708 patients who met the inclusion criteria were invited. Eligible patients were 
invited by letter. Two-hundred and seventy three (38.6%) patients declined the invitation, 81 
(11.4%) did not respond and 29 (4.1%) withdrew. The final sample included 310 patients (43.8% 
of those invited). Written informed consent was obtained from all patients following the 
provision of information sheets and the opportunity to ask questions (Ethics ref: 08/H0715/105). 
All the assessments were conducted in a suitable private room by a trained researcher. 
 
MEASURES 
Neuropsychological assessments  
A comprehensive range of neuropsychological tests were utilized to assess several cognitive 
domains; including memory, attention, executive function and verbal fluency (See Table 1). The 
3-subtests short-form measure of IQ (Wechsler Adult Intelligence Scale- WAIS-III) was scored 
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to produce an estimated full scale IQ (FSIQ-EST) which was derived using a formula by 
Tellegen and Briggs (1967).18 
 
Measures of Mood  
Mood was assessed to examine whether it influenced cognitive performance. 
 
The Positive and Negative Affect Scale (PANAS)  
PANAS is a 20-item self-report measure of positive (e.g. proud, alert, and inspired) and negative 
affect (e.g. upset, guilty, scared). Both subscales have shown good reliability: PA (alpha=0.89) 
and NA (alpha=0.85). Higher scores on each subscale indicate stronger affect.27 
  
Centre for Epidemiological studies Short Depression Scale (CESD-10)  
The CESD-10 is a self-report measure of depressive symptomology over the previous week. Ten 
items are rated on a 4 point scale ranging from “0= rarely/none of the time” to “3= All of the 
time”. Higher scores indicate greater depression. The CESD-10 has demonstrated satisfactory 
internal consistency(r= 0.84) and test-retest reliability(r=0.71).28 
 
State Trait Anxiety Inventory (STAI)  
The 6-item version of STAI was used to assess state anxiety associated with a medical condition.   
Higher scores indicate greater anxiety. The scale has shown good internal consistency (0.82).29 
 
Statistical analysis Data analysis was conducted using IBM SPSS, (version 21). Data was tested 
for the assumptions of normality; preliminary analysis indicated a non-normal distribution of the 
neuropsychological data. Square root and logarithmic transformations did not improve the data 
distribution. The overall level of missing data was <5%; to address this and obtain a complete 
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data set, a single imputation model was conducted using predictive mean matching (PMM)- 
further details of missing levels and imputation available from authors. 
The data (raw scores) were transformed into standardized scores (z-scores). The z-scores were 
derived using the Standard Deviation (SD) from age-matched normative data for each test, 
according to the scoring recommendations for each test (e.g. scoring manuals) (See 
supplementary file), which was then used to compare the performance of the patient group with 
that of a healthy population. Taking account of the direction of poorer performance (lower 
number correct in memory tests, slower performance in timed tests) patient performance of 1.5 
Standard Deviations (1.5 SD) or greater in the direction of poorer functioning than that of the 
normative group was used as an indicator of the presence of cognitive difficulty in the particular 
test. 1 SD, 1.5 SD and 2 SD are commonly used cut-off criteria in the neuropsychological 
literature30. Use of 1 SD is likely to identify false-positives whilst the stringent 2 SD criteria may 
increase the number of false negatives. The 1.5 SD criterion was selected as an attempt to 
balance the Type I and Type II errors31. Furthermore, this criterion is utilized in the diagnosis of 
Mild Cognitive Impairment32.  For ease of interpretation poor performance will be described as 
1.5 SD below the mean irrespective of the actual direction of scoring.  
 
Ingraham and Aiken30 provide useful data on determining criteria for impairment in multiple test 
batteries. On a single test 7% of a population would be expected to score 1.5 SD below the mean 
by chance30. In a battery of 15 tests (the present study yielded 15 scores from 8 
neuropsychological tests) 66% of a normal population would be expected to score 1.5 SD below 
the mean score on one test and 8% of a normal population would be expected to score 1.5 SD 
below the mean score on three tests.  
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A total mean composite z score was computed from all neuropsychological test z-scores to 
provide a single measure of neuropsychological function. Group differences were tested on 
demographic and clinical variables using Chi-square tests, Man-Whitney U or Kruskal-Wallis 
tests where appropriate (two-tailed significance levels reported). Analysis of Covariance was 
used to assess differences in cognitive test scores (z scores) between the structural complexity 
groups, while controlling for covariates educational attainment and mood as these are factors 
known to influence cognition.  
 
 
RESULTS 
Sample characteristics 
Of the 314 participants 4 did not provide complete neuropsychological data and were excluded 
from further analysis. Participants had a mean age of 33.3 years (SD 10.7) and 56% were male. 
Demographic and clinical characteristics of the sample are presented in Table 2. The Single 
Ventricle group was significantly younger than all other structural complexity groups 
(Transposition of the Great Arteries U=1845, p=.003 Tetralogy of Fallot U=1770, p<.001, 
Simple U=1714, p<.001).  
 
As expected clinical variables differed between patient groups. The Transposition of the Great 
Arteries group were significantly younger at age of first repair than the Tetralogy of Fallot, 
Single Ventricle and Simple groups (U=1066.0, p<.001, U=157.5, p<.001, U=1423.5, p<.001 
respectively). Tetralogy of Fallot patients were significantly younger at age of first repair than 
Single Ventricle patients (U=1142.5, p<.001). In addition Simple patients had significantly fewer 
interventions than Tetralogy of Fallot (U=1768.0, p<.001), Transposition of the Great Arteries 
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(U=1311.0, p<.001) and Single Ventricle patients (U=907.0, p<.001).  Single Ventricle patients 
had a greater number of interventions than Tetralogy of Fallot (U=1944.0, p=.005) and 
Transposition of the Great Arteries patients (U=2101.5, p=.036). Time since last operation was 
significantly longer in Transposition of the Great Arteries patients than Single Ventricle patients 
(U=1577.5, p<.001).  
 
 
Cognitive function in Adult Congenital Heart Disease compared to general population 
norms  
Cognitive performance of the Adult Congenital Heart Disease sample in comparison to age-
matched normative populations was assessed using z-scores calculated using the mean and the 
standard deviations of the normative data. Nearly three quarters (71.3%) of the sample performed 
1.5 SD below the mean of the normative data on at least one test, higher than the 66% expected 
in a normal population using a battery of 15 tests; i.e. only 5.3% greater than expected. 41% of 
the sample scored at least 1.5 SD below the normative mean on 3 or more tests, which was 
significantly greater than the 8% expected in the normal population30 The number of domains 
affected ranged from 1-13.  
 
Compared to normative data, The the greatest proportion majority of patients showed deficits in 
executive function (problem solving) (21.3% to 25.2%), divided attention (20.3%-23.9%), verbal 
fluency (22.3%) and fine motor function (20.6% -27.4%). Deficits were seen in WCST scores, 
which primarily assess executive function, with the exception of the WCST failure to maintain 
score which is dependent on working memory and attention rather than problem solving skills. 
This result is consistent with the lack of memory deficits seen on the Rey Auditory Verbal 
12 
 
Learning Test. Twenty four percent of the sample had an IQ score at least 1 SD below the 
normative mean of 100 (i.e. scored <85).  
 
Structural complexity group differences in cognitive functioning 
The percentage of patients in each group scoring 1.5 SD below the normative mean on at least 
one or three neuropsychological test scores is shown in Table 3. The Simple group showed the 
lowest levels of impairment with only 26.2% demonstrating impairment on three or more tests. 
The Simple group showed significantly less deficits compared to TGA on three or more tests 
(P<0.05). All other comparisons were non-significant.  All groups showed greater frequency of 
impairment than would be expected to occur in a normal population.30 Overall mean 
neuropsychological performance using a composite z score (norm adjusted standardised scores) 
indicated the highest performance (-1.004) occurred in the Simple group while the Transposition 
of the Great Arteries group had the poorest performance (-6.15) (see Figure 1).  
 
 
Analysis of covariance was used to investigate between group differences in overall 
neuropsychological performance with years of education and mood as covariates. Age was 
controlled for using age corrected normative scores. A significance level of p<0.01 was used to 
allow for multiple comparisons. 
 
Analysis of covariance revealed a group difference in composite neuropsychological test scores 
(Group: F (1,303)= 3.992, p=.002, partial ŋ2p =.038, Education: F= (1,303)= 33.29, p=.000, 
partial ŋ2p =.099, Positive affect: F (1,303)= 8.68, p=.003, partial ŋ2p =.028). Post hoc (Sidak) 
tests indicated a significant difference between the Simple and Transposition of the Great 
Arteries group (Adj Mean:  -5.9694, SE= 1.305 , p=.008).  
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Table 4 shows the proportion of patients within each structural complexity group showing 
impaired performance on the neuropsychological tests (>1.5 SD below the mean). See table 5 for 
2 SD cut-off indicating more extreme deficiencies. Both are higher than expected by chance 
compared to normative data.  
Analysis of covariance was used to explore between group differences in cognitive performance 
on each neuropsychological test. One neuropsychological function significantly differed between 
groups: divided attention (Trail Making Test -B) (Group:  F=5.01, p=.002,  =.047, Education: 
F=5.54, p=.019,  =.018, Positive affect: F=9.97, p=.002,  =.032). Post-hoc tests (Sidak) 
revealed that the Simple group performed significantly better than the Tetralogy of Fallot (Adj 
Mean =.958, SE=.180, p=.009) and Single Ventricle (Adj Mean =.147, SE=.177, p=.007).  
 
 
Borderline significant differences were found in response inhibition (Stroop-Word test) (Group: 
F=3.56, p=.015,  =.034), executive functioning (WCST-No of categories) (Group: F = 3.49, P 
=.016,  =.033) and motor function and dexterity (Grooved Pegboard) (Group: F=3.30, p = .021, 
 =.032).   
 
IQ scores 
Results indicated that the mean scores for all four groups were within the ‘average’ IQ category 
as classified by Wechsler (IQ= 90-109). No significant difference was seen between group IQ 
scores after controlling for education and mood (Group: F=1.04, p=.375). Visual inspection of 
the data suggested the Simple group attained the highest IQ (mean=100.4), followed by Single 
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Ventricle (mean =96.6), Transposition of the Great Arteries (mean =95.2) and lastly Tetralogy of 
Fallot (mean =95.04). Group: F=(3,299)=1.04, p = .375,  =.001. 
 
 
DISCUSSION 
The persistence of cognitive deficits into adulthood as a result of Congenital Heart Disease and 
its associated treatments was examined in this study. The cognitive function of Adult Congenital 
Heart Disease patients was compared to age-matched population norms, and differences in 
cognitive function between structural complexity groups assessed.  
 
The results indicated that a considerable proportion of Adult Congenital Heart Disease patients 
had cognitive abilities below that of age-matched healthy adults in a range of domains of 
cognitive functioning including executive function, divided attention and fine motor function. 
These findings suggest Adult Congenital Heart Disease patients may have difficulty attending to 
multiple tasks, dealing with novel and complex situations and performing fine motor tasks. A 
considerable number of patients displayed deficits in multiple domains. Almost a quarter of the 
sample showed deficits in IQ suggesting a generalized effect of congenital heart disease on 
cognition. However, in line with previous research, memory was found to be largely unaffected.9 
 
As expected, investigation of structural complexity group differences indicated that patients in 
the ‘Simple’ group had better cognitive function than other groups. This indicates that the more 
morphologically complex the disease is, the greater the possibility of experiencing cognitive 
deficits. A possible explanation of this pattern is the inherent risk involved with having a severe 
form of congenital heart disease, including an increased risk for congenital brain anomalies.33 
Patients with severe heart conditions also have an increased risk of cognitive deficits due to 
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frequent surgery, particularly high-risk surgical interventions such as cardio-pulmonary bypass,34 
pre- and postoperative poor cerebral perfusion, and seizures.35The findings of the present study 
are consistent with a meta-analysis reporting patients with more severe forms of congenital heart 
disease  having poorer levels of cognitive functioning than those with less severe forms.7  
 
The general cognitive assessment of IQ did not show statistically significant differences between 
patient groups. This finding, in contrast to the assessment of specific domains of cognition, 
emphasizes the limitations of generalized measures of cognitive function such as IQ. 
 
Executive function and other so called ‘higher-order’ cognitive skills were the most impaired 
domain within our sample. Deficits of this nature have the potential to impact on educational 
attainment and employment prospects.36 Furthermore they may cause difficulties for patients 
during their daily lives when conducting instrumental activities of daily living such as managing 
finances and problem solving.  
 
LIMITATIONS 
While the current study is one of the largest and first of its kind to explore cognitive functioning 
in Adult Congenital Heart Disease patients across a range of cognitive domains and levels of 
disease complexity several limitations must be considered.  The sample included the major Adult 
Congenital Heart Disease structural complexity groupings however it does not encompass all 
forms of Adult Congenital Heart Disease, and generalizability is restricted to the conditions 
included in the study. Although a broad range of cognitive domains were assessed in the study 
practicalities, including participant fatigue and time constraints, limited inclusion of a greater 
range of assessments. A broader range of memory abilities and visuo-spatial skills could be 
explored in future studies. Cognitive performance within the sample was compared against 
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normative data corrected for age. While this gives a good indication of the sample’s performance 
against a healthy population the inclusion of an age matched health control group may have 
further strengthened the study design. 
 
The present study highlights the significant extent of cognitive dysfunction present in patients 
with Adult Congenital Heart Disease compared to established normative data. Further work is 
now needed to identify the underlying mechanisms that can explain the specific causes of these 
deficits, and inform tools and interventions to evaluate and address potential deficits within 
clinical practice. Investigations into the long-term stability of these deficits will further inform 
clinicians and health care practitioners to be able to identify vulnerable groups and offer 
appropriate ongoing support and care.  
 
IMPLICATIONS 
This paper reports one of the first studies to include a large sample of Adult Congenital Heart 
Disease patients and assesses a wide range of cognitive domains as opposed to a composite 
measure of cognitive functioning. It is hoped that this may enable clinicians to identify and 
intervene with patients at an increased risk of cognitive deficits, and enable provision of 
additional developmental support where appropriate. 
 
SOURCES OF FUNDING 
This work was supported by the University College London Hospital (UCLH)/University College 
London National Institute for Health Research, Comprehensive Biomedical research center 
(UCLH Project ID number: 08/0326). 
 
CONTRIBUTORSHIP STATEMENT 
17 
 
Professor Stanton Newman is the guarantor and the principal investigator of the study. Manavi 
Tyagi drafted the paper and was involved in the design and execution of the study. Catherine 
Hurt and Lorna Rixon made significant contributions to the drafting of the paper. Theodora 
Fteropoulli, Nathalie Picaut and Fiona Kennedy were involved with the execution of the study.  
Dr Shay Cullen, Professor John Deanfield, and Professor Stanton Newman were involved with 
the design and management of the study. All authors contributed to the writing and review of the 
paper.  
  
ACKNOWLEDGEMENTS  
We would like to acknowledge the University College London Hospital (UCLH)/University 
College London National Institute for Health Research, Comprehensive Biomedical research 
center for supporting this research. The Authors would like to thank all the participants and 
members at the Heart Hospital, London who assisted in completing this study. 
 
CONFLICT OF INTEREST 
 None declared  
  
18 
 
References 
1. Gatzoulis M, Webb G, Daubeney P. Diagnosis and management of Adult Congenital 
Heart Disease. 2nd ed Churchill Livingstone: 2011. 
2. Wren C, O'Sullivan J. Survival with congenital heart disease and need for follow up in 
adult life. Heart 2001;85:438-443. 
3. Gatzoulis M, Hechter S, Siu S, et al. Outpatient clinics for adults with congenital heart 
disease: increasing workload and evolving patterns of referral. Heart 1999;81:57-61. 
4. Fteropoulli T, Stygall J, Cullen S, et al. Quality of life of adult congenital heart disease 
patients: a systematic review of the literature. Cardiol Young 2013;23:473-485. 
5. Tyagi M, Austin K, Stygall J, et al. What do we know about cognitive functioning in adult 
congenital heart disease? Cardiol Young 2014;24:13-19.  
6. Schaefer C, Rhein MV, Knirsch W, et al. Neurodevelopmental outcome, psychological 
adjustment, and quality of life in adolescents with congenital heart disease. Dev Med 
Child Neurol 2013;55:1143-1149. 
7. Karsdorp PA, Everaerd W, Kindt M, et al. Psychological and cognitive functioning in 
children and adolescents with congenital heart disease: A meta-analysis. J Pediatr 
Psychol 2007;32:527-541. 
8.  Eide MG, Skjaerven R, Irgens LM. Associations of birth defects with adult intellectual 
performance, disability and mortality: population-based cohort study. Pediatr Res 
2006;59:848-53. 
9. Daliento L, Mapelli D, Russo G, et al. Health related quality of life in adults with repaired 
tetralogy of fallot: psychosocial and cognitive outcomes. Heart 2005;91:213-218. 
10. Bellinger DC, Newburger JW. Neuropsychological, psychosocial, and quality-of-life 
outcomes in children and adolescents with congenital heart disease. Prog Pediatr Cardiol 
2010;29:87-92. 
19 
 
11. Newburger JW, Jonas RA, Wernovsky G, et al. A comparison of the perioperative 
neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary 
bypass in infant heart surgery. N Engl J Med 1993;329:1057-1064. 
12. Daliento L, Mapelli D, Volpe B, et al. Measurement of cognitive outcome and quality of 
life in congenital heart disease. Heart 2006: 569–574 
13. Wernovsky G, Stiles K, Gauvreau K, et al. Cognitive development after the Fontan 
operation. Circulation 2000: 883–889 
14. Utens EM, Verhulst FC, Erdman RA, et al. Psychosocial functioning of young adults after 
surgical correction for congenital heart disease in childhood: a follow-up study. J 
Psychosom Res 1994: 745–758. 
15. Utens EM, Versluis D, Verhulst FC, et al. Psychopathology in young adults with 
congenital heart disease. Follow-up results. Eur Heart J 1998: 647–651. 
16. Newburger JW, Silbert AR, Buckley LP, et al. Cognitive function and age at repair of 
transposition of the great arteries in children. N Egl J Med 1984;301:1495-1499. 
17. Pugsley W, Klinger L, Paschalis C, et al. Microemboli and cerebral impairment during 
cardiac surgery. Vasc Surg 1990;24:34-43. 
18. Tellegen A, Briggs PF. Old wine in new skins: grouping Wechsler subtests into new 
scales. J Consult Psychol 1967;31:499-506. 
19. Ruff RM, Light RH, Parker SB, et al. Benton controlled oral word association test: 
Reliability and updated norms. Arch. Clin. Neuropsychol1996;11:329-338. 
20. Matthew CG, Klove K. Instruction manual for the Adult Neuropsychological Test Battery 
Madison Wisc: University of Wisconsin Medical School 1964. 
21. Michael S. Rey auditory verbal learning test: a handbook. Los Angeles: Western 
Psychological Services 1996. 
22. Trenerry MR, Crosson B, DeBoe J, Leber WR. Stroop Neuropsychological Screening 
20 
 
Test. Odessa. FL: Psychological Assessment Resources 1989.   
23. Smith A. The Symbol Digit Modalities Test Manual Western Psychological Services: Los 
Angeles 1982. 
24. Reitan RM. Trail Making Test: Manual for administration and scoring: Reitan 
Neuropsychology Laboratory 1986. 
25. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test-64 card 
version (WCST-64). Odessa FL: Psychological Assessment Resources; 2000. 
26. Wechsler D. Wechsler Adult Intelligence Scale, 3rd ed. The   Psychological Corporation: 
New York 1997.   
27. Watson D, Lee AC, and Tellegen A. Development and validation of brief measures of 
positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063-1070. 
28. Andresen EM, Malmgren JA, Carter WB, et al. Screening for depression in well older 
adults: evaluation of a short form of the CES-D. Am J Prev Med 1994;10:77-84. 
29. Marteau TM, Bekker H. The development of a six‐ item short‐ form of the state scale of 
the Spielberger State—Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-
306. 
30. Ingraham LJ, Aiken CB. An empirical approach to determining criteria for abnormality in 
test batteries with multiple measures. Neuropsychology 1996;10:120-124. 
31. Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological 
assessment (5th ed.). New York: Oxford University Press. 
32. Petersen, R. C. (2004). "Mild cognitive impairment as a diagnostic entity." Journal of 
Internal Medicine 256(3): 183-94. 
33. Glauser TA, Rorke LB, Weinberg PM, et al. Congenital brain anomalies associated with 
the hypoplastic left heart syndrome. Pediatrics 1990;85:984-990. 
21 
 
34. Stavinoha PL, Fixler DE, Mahony L. Cardiopulmonary bypass to repair an atrial septal 
defect does not affect cognitive function in children. Circulation 2003;107:2722-2725. 
35. Goldberg CS, Schwartz EM, Brunberg JA, et al. Neurodevelopmental outcome of patients 
after the Fontan operation: a comparison between children with hypoplastic left heart 
syndrome and other functional single ventricle lesions. J Pediatr 2000;137:646-652. 
36. Marino B, Lipkin P, Newburger J, et al. On behalf of the American Heart Association 
Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the 
Young, Council on Cardiovascular and Stroke Nursing, and Stroke Council. 
Neurodevelopmental outcomes in children with congenital heart disease: evaluation and 
management: a scientific statement from the American Heart Association. Circulation 
2012;126:1143-72. 
 
  
22 
 
 
 
 
 
Table 1 Summary of neuropsychological assessments 
Tests utilized  Major cognitive 
function assessed 
Definition of cognitive function 
assessed 
Controlled Oral Word 
Association test (COWA-
FAS)19 
Verbal fluency Speed and ease of verbal production 
Grooved Pegboard 
(GPB)20 
Manual and motor 
dexterity and functioning 
Speed and accuracy of manipulation of 
fine objects with the hands 
Rey Auditory Verbal 
Learning Test (RAVLT)21 
Verbal learning and 
memory, delayed and 
immediate recall 
Ability to learn new information and to 
store and retrieve information 
Stroop 
Neuropsychological 
Screening test (SNST)22 
Executive function: 
response inhibition  
Ability to respond appropriately in 
novel situations; ability to perform an 
action when faced with a competing and 
more familiar action 
Symbol Digit Modalities 
Test (SDMT)23 
Complex visual scanning  The ability to visually locate a target 
within a range of complex figures 
Trail making test (TMT) 
A and B24 
Divided attention  The ability to respond to multiple tasks 
simultaneously 
Wisconsin Card Sorting 
Test -64 (WCST)25 
Executive function: 
problem solving  
Ability to respond appropriately in 
novel situations; ability to plan and use 
initiative 
Wechsler Adult 
Intelligence Scale     
(WAIS-III)26 
IQ – general intelligence General cognitive ability 
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Table 2 Sample demographic and clinical characteristics (by disease classification) 
  TOF 
N=81 
(26.1%) 
TGA 
N=80  
(25.8%) 
SV 
N=65 
(21.0%) 
SIMPLE 
N=84  
(27.1%) 
Test statistic 
(p) 
Age (years) Mean (SD) 34.6 
(11.0) 19-
66 
31.6 (6.5)  
19-50 
28.6 (7.7) 
18-58 
37.1 (13.7)  
19-76 
H= 
19.734 
 (<.001) 
Education (years)  Mean (SD) 13.0 (2.8) 13.4 (2.7) 13.8 (2.7) 13.6 (3.2) H=3.08 
(.370) 
Gender (Male) N (%) 43 (53.1) 51 (63.8) 43 (66.2) 37 (44.0) χ2=8.814 
(.032) 
White British N (%) 72 (88.9) 71 (88.8) 51 (78.5) 68 (81.0) χ2=4.575 
(.206) 
Married/partner N (%) 44 (54.3) 36 (45.0) 33 (50.7) 45(53.6) χ2=1.983 
(.576) 
Employed N (%) 56 (69.1) 59 (73.8) 44 (67.7) 53 (63.1) χ2=2.678 
(.444) 
Depression Mean (SD) 6.2 (4.7) 5.9 (4.3) 8.3 (6.2) 8.0 (6.6) H=7.682 
(.053) 
Anxiety Mean (SD) 9.9 (3.7) 9.9 (3.4) 11.0 (3.8) 10.2 (3.6) H=4.666 
(.198) 
Positive affect Mean (SD) 33.7 (8.2) 34.4 (8.0) 32.8 (8.0) 32.5 (8.3) H=2.371 
(.499) 
 
Negative affect Mean (SD) 17.8 (7.1) 16.4 (6.1) 18.6 (6.6) 17.8 (6.7) H=4.487 
(.213) 
Age at first repair 
(months) 
Mean (SD) 71.8 
(115.0) 
14.7(23.4) 98.9 (61.9) 136.8 
(193.5) 
H=84.055 
(<.001) 
Total No. 
interventions*  
Mean (SD) 2.4 (1.2) 2.6 (1.3) 3.1 (1.6) 1.5 (0.8) H=74.02 
(<.001) 
Years since last 
intervention* 
Mean (SD) 15.9 
(13.8) 
20.0 (12.0) 13.1 (8.5) 15.2 (12.9) H= 
12.729 
(.012) 
NYHA Median 
(Interquartile 
range) 
1 (0) 1 (0) 1 (0) 1 (0) χ2=12.134 
(.107)** 
NYHA= New York Health Association functional classification 
H= Kruskal-Wallis test, χ2= Chi-square test 
*Interventions include catheter interventioncather lab, palliative or reparative surgery 
** Fisher’s Fisher’s exact value reported 
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Table 3 Percentage of patients scoring 1.5 SD below the normative mean score by structural complexity group 
 
SD, Standard Deviation; TOF, Tetralogy of Fallot; TGA, Transposition of the Great Arteries; SV, Single Ventricle
Group Percentage  
>1.5 SD 
below the 
normative 
mean on at 
least 1 test 
Percentage  
>1.5 SD 
below the 
normative 
mean on at 
least 3 
tests 
Tests 
0 
N 
(%) 
 
1 
N  
(%) 
 
2  
N  
(%) 
 
3  
N  
(%) 
 
4  
N 
(%) 
 
5  
N   
(%) 
 
6  
N 
(%) 
 
7 
N 
(%) 
 
8  
N 
(%) 
 
9  
N 
(%) 
 
10  
N 
(%) 
 
11  
N 
(%) 
 
12 
N 
(%) 
 
13  
N 
(%) 
                 
TOF 72.8 n=59 44.4 n=36 22 
(27.2) 
9  
(11.1) 
14 
(17.3) 
8  
(9.9) 
8 
(9.9) 
9 
(11.1) 
3 
(3.7) 
3 
(3.7) 
1 
(1.2) 
2 
(2.5) 0 
2 
(2.5) 0 0 
                 
TGA 77.5 n=62 48.8 n= 39 18 
(22.5) 
13 
(16.3) 
10 
(12.5) 
15 
(18.8) 
4 
(5.0) 
3  
(3.8) 
9 
(11.3) 
3 
(3.8) 
1 
(1.3) 
1 
(1.3) 
1 
(1.3) 
1 
(1.3) 
1 
(1.3) 
1 
(1.3) 
                 
SV 72.3 n=47 44.6 n= 29 18 
(27.7) 
11 
(16.9) 
7  
(10.8) 
8  
(12.3) 
5 
(7.7) 
2  
(3.1) 
6 
(9.2) 
3 
(4.6) 
2 
(3.1) 
1 
(1.5) 0 0 
2 
(3.1) 0 
                 
Simple 63.1 n= 53 26.2 n= 22 31 
(36.9) 
19 
(22.6) 
12 
(14.3) 
8  
(9.5) 
5 
(6.0) 
2  
(2.4) 
4 
(4.8) 
1 
(1.2) 
1 
(1.2) 0 0 
1 
(1.2) 0 0 
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Table 4: Proportion of participants scoring >1.5 SD below the mean for each of the 
neuropsychological assessments in each of the four structural complexity groups  
 
ToF 
N (%) 
TGA 
N (%) 
SV 
N (%) 
Simple 
N (%) 
TMT-A 15 (18.5) 21 (26.3) 14 (21.5) 13 (15.5) 
TMT-B 22 (27.2) 16 (20.0) 23 (35.4) 13 (15.5) 
COWA 17 (21.0) 24 (30.0) 12 (18.5) 16 (19.0) 
GP-Dominant 24 (29.6) 29 (36.3) 19 (29.2) 13 (15.5) 
GP-Non Dominant 18 (22.2) 20 (25.0) 15 (23.1) 11 (13.1) 
Stroop- Colour 7 (8.6)* 10 (12.5) 8 (12.3) 8 (9.5) 
Stroop-Colour word 12 (14.8) 16 (20.0) 18 (27.7) 10 (11.9) 
WCST-No Categories 24 (29.6) 25 (31.3) 16 (24.6) 13 (15.5) 
WCST-Failure to 
maintain set 9 (11.1) 6 (7.5)* 4 (6.2)* 4 (4.8)* 
WCST-Trials 1
st
 
Category 5 (6.2)* 4 (5)* 6 (9.2) 3 (3.6)* 
WCST-Errors 23 (28.4) 18 (22.5) 12 (18.5) 16 (19) 
WCST-Conceptual 
Level 21 (25.9) 18 (22.5) 17 (26.2) 14 (16.7) 
Rey- Total Acquisition 8 (9.9) 9 (11.3) 5 (7.7)* 5 (6.0)* 
Symbol digit Written 11 (13.6) 11 (13.8) 11 (16.9) 3 (3.6)* 
Symbol digit Oral 9 (11.1) 11 (13.8) 5 (7.7)* 5 (6.0)* 
*<8% which would be expected in the normal population Ingraham and Aiken30 
 
 
Table 5: Proportion of participants scoring >2 SD below the mean for each of the 
neuropsychological assessments in each of the four structural complexity groups  
 
ToF 
N (%) 
TGA 
N (%) 
SV 
N (%) 
Simple 
N (%) 
TMT-A 10 (12.3) 15 (18.8) 12 (18.5) 9 (10.7) 
TMT-B 17 (21.0) 12 (15.0) 15 (23.1) 9 (10.7) 
COWA 8 (9.9) 9 (11.3) 4 (6.2) 6 (7.1) 
GP-Dominant 17 (21.0) 21 (26.3) 16 (24.6) 12 (14.3) 
GP-Non Dominant 11 (13.6) 12 (15.0) 9 (13.8) 5 (6.0) 
Stroop- Colour 7 (8.6) 10 (12.5) 8 (12.3) 8 (9.5) 
Stroop-Colour word 7 (8.6) 10 (12.5) 8 (12.3) 8 (9.5) 
WCST-No Categories 14 (17.3) 11 (13.8) 7 (10.8) 5 (6.0) 
WCST-Failure to 
maintain set 9 (11.1) 6 (7.5) 4 (6.2) 4 (4.8)* 
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WCST-Trials 1
st
 
Category 
5 (6.2) 4 (5.0) 6 (9.2) 3 (3.6) * 
WCST-Errors 13 (16.0) 12 (15.0) 9 (13.8) 8 (9.5) 
WCST-Conceptual 
Level 
11 (13.6) 13 (16.3) 10 (15.4) 8 (9.5) 
Rey- Total Acquisition 1 (1.2) * 2 (2.5) * 1 (1.5) * 3 (3.6) * 
Symbol digit Written 8 (9.9) 7 (8.8) 7 (10.8) 2 (2.4) * 
Symbol digit Oral 5 (6.2) 5 (6.3) 5 (7.7) 2 (2.4)* 
*<5% which would be expected in the normal population Ingraham and Aiken30 
 
